| 6737- | Dipy, | Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19 (TOLD) |
| - | Trial, | Nor, | NA |
| 6265- | DL, | Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee |
| - | Trial, | Var, | NA |
| 6266- | DL, | Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer |
| - | Trial, | BC, | NA |
| 6279- | DL, | Human breast tissue disposition and bioactivity of limonene in women with early stage breast cancer |
| - | Trial, | BC, | NA |
| 4917- | DSF, | Chemo, | Cu, | Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma |
| - | Trial, | GBM, | NA |
| 6803- | EA, | Effects of Ellagic Acid on Oxidative Stress Index, Inflammatory Markers and Quality of Life in Patients With Irritable Bowel Syndrome: Randomized Double-blind Clinical Trial |
| - | Trial, | IBD, | NA |
| 6612- | Ech, | Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | Nor, | NA |
| 6603- | Ech, | doxoR, | The effect of Echinacea purpurea on the pharmacokinetics of docetaxel |
| - | Trial, | Var, | NA |
| 7225- | EGb 761, | Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial |
| - | Trial, | AD, | NA |
| 7232- | EGb 761, | Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial |
| - | Trial, | AD, | NA |
| - | Trial, | Nor, | NA |
| - | Trial, | Nor, | NA |
| 653- | EGCG, | Phase 2 Trial of Daily, Oral Polyphenon E in Patients with Asymptomatic, Rai Stage 0-II Chronic Lymphocytic Leukemia(CLL) |
| - | Trial, | CLL, | NA |
| 6790- | EPA, | Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia |
| - | Trial, | Lung, | NA |
| 6792- | EPA, | Effect of Eicosapentaenoic Acid on Body Composition and Inflammation Markers in Patients with Head and Neck Squamous Cell Cancer from a Public Hospital in Mexico |
| - | Trial, | HNSCC, | NA |
| 5234- | Ex, | Intense Walking Exercise Affects Serum IGF-1 and IGFBP3 |
| - | Trial, | Nor, | NA |
| 5235- | Ex, | Effect of Low-Intensity Aerobic Exercise on Insulin-Like Growth Factor-I and Insulin-Like Growth Factor-Binding Proteins in Healthy Men |
| - | Trial, | Nor, | NA |
| 5230- | Ex, | Effects of an acute maximal exercise bout on serum insulin-like growth factor-1 in adults with MDD |
| - | Trial, | Nor, | NA |
| 4137- | Ex, | The impact of exercise on patients with dementia |
| - | Trial, | AD, | NA |
| 5063- | Ex, | A randomized controlled trial on the efficacy of supervised exercise training in reducing IGF-1 levels in breast cancer survivors of the Movis’ cohort |
| - | Trial, | BC, | NA |
| 6866- | FA, | Ang, | Effects of Ferulic Acid and Angelica archangelica Extract (Feru-guard ®) on Mild Cognitive Impairment: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Prospective Trial |
| - | Trial, | AD, | NA |
| 6867- | FA, | Ang, | Effect of Feru-guard 100M on amyloid-beta deposition in individuals with mild cognitive impairment |
| - | Trial, | AD, | NA |
| 6870- | FA, | Folic acid supplementation improves cognitive function in participants with cerebral small vascular disease-related cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 6883- | FA, | Ang, | Effect of ferulic acid and Angelica archangelica extract on behavioral and psychological symptoms of dementia in frontotemporal lobar degeneration and dementia with Lewy bodies |
| - | Trial, | AD, | NA |
| 6884- | FA, | Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
| - | Trial, | AD, | NA |
| 6951- | FA, | Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI |
| - | Trial, | AD, | NA |
| - | Trial, | AD, | NA |
| 6949- | FA, | VitB12, | A controlled trial of homocysteine lowering and cognitive performance |
| - | Trial, | AD, | NA |
| 6948- | FA, | VitB12, | A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people |
| - | Trial, | AD, | NA |
| 6947- | FA, | Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 6954- | FA, | Folic acid as a potential therapeutic agent for Alzheimer's disease: Effects on inflammatory cytokines, amyloid deposition, and neurotransmitter metabolism |
| - | Trial, | AD, | NA |
| 6956- | FA, | VitB12, | A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients |
| - | Trial, | AD, | NA |
| 6961- | FA, | VitB12, | VitB6, | Silicon, | Alum | B Vitamins Prevent Iron-Associated Brain Atrophy and Domain-Specific Effects of Iron, Copper, Aluminum, and Silicon on Cognition in Mild Cognitive Impairment |
| - | Trial, | AD, | NA |
| 4064- | FA, | VitB6, | VitB12, | High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 4070- | FA, | Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial |
| - | Trial, | AD, | NA |
| 4074- | FA, | VitB12, | Associations between Alzheimer's disease and blood homocysteine, vitamin B12, and folate: a case-control study |
| - | Trial, | AD, | NA |
| 4044- | FA, | Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial |
| - | Trial, | AD, | NA |
| 1914- | Fer, | VitC, | TMZ, | Rad, | Pharmacologic Ascorbate and Ferumoxytol Combined with Temozolomide and Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma |
| - | Trial, | GBM, | NA |
| 6920- | FIS, | A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design |
| - | Trial, | BC, | NA |
| 6876- | Flav, | Flavonoid-rich orange juice is associated with acute improvements in cognitive function in healthy middle-aged males |
| - | Trial, | AD, | NA |
| 6931- | FLS, | Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies |
| - | Trial, | AD, | NA |
| 6933- | FLS, | AudGS, | Gamma sensory stimulation in mild Alzheimer's dementia: An open-label extension study |
| - | Trial, | AD, | NA |
| - | Trial, | AD, | NA |
| 4121- | FLS, | Sensory-Evoked 40-Hz Gamma Oscillation Improves Sleep and Daily Living Activities in Alzheimer’s Disease Patients |
| - | Trial, | AD, | NA |
| 8303- | FS, | The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed |
| - | Trial, | Nor, | NA |
| 8315- | FS, | Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen |
| - | Trial, | Pca, | NA | - | Trial, | BPH, | NA |
| 8310- | FS, | Can flaxseed “milk” prevent anthracycline mediated cardiotoxicity in women with breast cancer (CANFLAX-BC)? |
| - | Trial, | BC, | NA |
| 8307- | FS, | lign, | Efficacy and safety of a flaxseed hull extract in the symptomatic management of benign prostatic hyperplasia: a parallel, randomized, double-blind, placebo-controlled, pilot study |
| - | Trial, | BPH, | NA |
| 8300- | FS, | Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery |
| - | Trial, | Pca, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid